A groundbreaking discovery published in Nature Immunology has shed light on why the immune system is less aggressive toward self-antigens, offering new opportunities to enhance cancer immunotherapy.
Moores Cancer Center has received a $1 million donation from pharmaceutical company Pfizer to support an innovative new program designed to bolster early cancer detection and prevention efforts.
A study by UC San Diego School of Medicine described a novel medical student service-learning initiative that provides free laser tattoo removal services for justice-impacted adults reintegrating into the community.
Researchers at UC San Diego have confirmed the presence of xylazine in the illicit drug supply at the U.S.-Mexico border. While xylazine remains less common in the Western U.S., border cities serve as key trafficking hubs and may have higher rates of emerging substances.
UC San Diego bioengineers have shed new light on how a type of heart valve disease—aortic valve stenosis—progresses differently in males and females. The research paves the way for treatments that can be tailored to a patient's biological sex.
Researchers at UC San Diego have developed advanced deep learning techniques that could revolutionize treatment planning for breast cancer radiotherapy – making it faster and improving its quality.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
